Gateway Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
4,713
-4,273
-48% -$245K 0.02% 662
2026
Q1
$545K Buy
+8,986
New +$524K 0.02% 553
2024
Q2
Sell
-3,854
Closed -$209K 266
2024
Q1
$209K Sell
3,854
-680
-15% -$34.6K 0.08% 226
2023
Q4
$233K Buy
4,534
+535
+13% +$28.1K 0.09% 191
2023
Q3
$232K Sell
3,999
-57
-1% -$3.49K 0.04% 228
2023
Q2
$259K Buy
+4,056
New +$272K 0.05% 199

Other funds holding BMY

Gateway Wealth Partners's BMY Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 48% in Q2 2026, selling an estimated $245K and leaving 4,713 shares worth $272K. The position accounts for 0.02% of the portfolio, ranked #662.

Gateway Wealth Partners first reported a position in BMY in Q2 2023 and has held it in 6 quarters since. The position peaked at $545K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Gateway Wealth Partners held 4,713 shares of Bristol-Myers Squibb worth $272K as of Q2 2026.
  • Gateway Wealth Partners sold 4,273 Bristol-Myers Squibb shares in Q2 2026, an estimated $245K.
  • Bristol-Myers Squibb made up 0.02% of Gateway Wealth Partners's portfolio in Q2 2026, its #662 holding.
  • Gateway Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 6 quarters since.
  • Gateway Wealth Partners's Bristol-Myers Squibb position peaked at $545K in Q1 2026.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.